Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Marc HumbertHarrison W FarberHossein-Ardeschir GhofraniRaymond L BenzaDennis BusseChristian MeierMarius M Hoeper

Published in: The European respiratory journal (2019)

This analysis confirms and extends the results of the registry analyses, supporting the value of goal-oriented treatment in PAH. Further assessment of these methods in patients with CTEPH is warranted.

Keyphrases

pulmonary arterial hypertension
pulmonary hypertension
pulmonary artery
risk assessment
polycyclic aromatic hydrocarbons
drug induced